| Product NDC: | 52584-061 |
| Proprietary Name: | Cefazolin |
| Non Proprietary Name: | Cefazolin Sodium |
| Active Ingredient(s): | 500 mg/500mg & nbsp; Cefazolin Sodium |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52584-061 |
| Labeler Name: | General Injectables & Vaccines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065047 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100301 |
| Package NDC: | 52584-061-10 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 BAG (52584-061-10) > 500 mg in 1 VIAL, SINGLE-DOSE |
| NDC Code | 52584-061-10 |
| Proprietary Name | Cefazolin |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 BAG (52584-061-10) > 500 mg in 1 VIAL, SINGLE-DOSE |
| Product NDC | 52584-061 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cefazolin Sodium |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20100301 |
| Marketing Category Name | ANDA |
| Labeler Name | General Injectables & Vaccines, Inc. |
| Substance Name | CEFAZOLIN SODIUM |
| Strength Number | 500 |
| Strength Unit | mg/500mg |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |